Curetis NV (CURE)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Curetis NV (CURE) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012942
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:59
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Curetis NV (Curetis) is a medical device company that offers molecular diagnosis solutions. The company offers diagnostic systems developed with Unyvero platform for severe infectious diseases. Its products are used in rapid diagnosis for variety of cartridges, diseases such as pneumonia, implant and tissue infections; and in the laboratory for multiplex polymerase chain reaction pcr diagnostics. It caters to biotechnology, contract research, medical, healthcare and pharmaceutical companies, among others. The company has operational presence in France, Switzerland, Netherlands, the UK, the US and Germany, among others. It sells its products through a network of distributors in Germany. Curetis is headquartered in Stuttgart, Baden-Wurttemberg, Germany.

Curetis NV (CURE) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Curetis NV, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Curetis NV, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Curetis NV, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Curetis NV, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Curetis NV, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Curetis NV, Medical Equipment, Deal Details 12
Asset Purchase 12
Curetis to Acquire qPCR Platform from Carpegen and Systec 12
Curetis to Acquire Assets from Siemens Technology Accelerator 14
Venture Financing 15
Curetis Raises USD18 Million in Extended Series B Venture Financing 15
Curetis Raises US$16.3 Million In Series B Financing 17
Curetis Secures Additional US$13.3 Million In Series A Venture Financing 19
Partnerships 21
Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept 21
Curetis Enters Into Licensing Agreement With Cempra For Unyvero 22
Curetis to Enter into Agreement with MGI Tech 23
Acumen Research Labs Enters into Distribution Agreement with Curetis 24
Curetis Enters into Distribution Agreement with Arrow Diagnostics 25
Curetis And Laboratorios LETI Enter Into Distribution Agreement For Unyvero In Spain And Portugal 26
Curetis Enters Into Distribution Agreement With Elitech 27
Curetis Enters Into Co-Development Agreement With Heraeus Medical For Unyvero 28
Curetis Enters Into Distribution Agreement With Advanced Technology For Unyvero Solution 29
Curetis Enters Into Agreement With Sanofi Pasteur For Unyvero Platform 30
Equity Offering 31
Curetis Raises USD44 Million in IPO 31
Curetis NV – Key Competitors 32
Curetis NV – Key Employees 33
Curetis NV – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Recent Developments 35
Strategy And Business Planning 35
Apr 06, 2017: Curetis Starts Subsidiary Ares Genetics to Advance Genetic Antibiotic Resistance Testing 35
Financial Announcements 37
Nov 15, 2017: Curetis Publishes Business and Financial Update for the First Nine Months of 2017 37
Aug 16, 2017: Curetis Announces Financial Results for the First Six Months of 2017 39
May 24, 2017: Curetis Provides Business and Financial Update for the First Quarter 2017 42
Apr 12, 2017: Curetis Reports Full-Year 2016 Financial Results and Updates 2017 Guidance 44
Nov 18, 2016: Curetis Publishes Business and Financial Update for the First Nine Months 2016 46
Aug 19, 2016: Curetis Reports Financial Results for the First Six Months of 2016 48
May 20, 2016: Curetis Publishes First Quarter 2016 Business and Financial Update 50
Apr 12, 2016: Curetis Publishes Full-Year 2015 Financial Results and Introduces 2016 Guidance 52
Corporate Communications 54
Aug 16, 2017: Curetis Announces Management Board Changes 54
Apr 12, 2017: Curetis Expands Supervisory and Medical Advisory Boards 55
Jul 04, 2016: Curetis Appoints Christopher M. Bernard as Chief Executive Officer of Newly-Formed U.S. Subsidiary 56
Jan 11, 2016: Curetis Establishes Medical Advisory Board with Internationally Renowned Experts 57
Other Significant Developments 58
Jun 06, 2016: Curetis and Axonlab sign multi-market European distribution agreement 58
Appendix 59
Methodology 59
About GlobalData 59
Contact Us 59
Disclaimer 59

List of Tables
Curetis NV, Medical Equipment, Key Facts, 2016 2
Curetis NV, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Curetis NV, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Curetis NV, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Curetis NV, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Curetis NV, Deals By Market, 2011 to YTD 2017 9
Curetis NV, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Curetis to Acquire qPCR Platform from Carpegen and Systec 12
Curetis to Acquire Assets from Siemens Technology Accelerator 14
Curetis Raises USD18 Million in Extended Series B Venture Financing 15
Curetis Raises US$16.3 Million In Series B Financing 17
Curetis Secures Additional US$13.3 Million In Series A Venture Financing 19
Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept 21
Curetis Enters Into Licensing Agreement With Cempra For Unyvero 22
Curetis to Enter into Agreement with MGI Tech 23
Acumen Research Labs Enters into Distribution Agreement with Curetis 24
Curetis Enters into Distribution Agreement with Arrow Diagnostics 25
Curetis And Laboratorios LETI Enter Into Distribution Agreement For Unyvero In Spain And Portugal 26
Curetis Enters Into Distribution Agreement With Elitech 27
Curetis Enters Into Co-Development Agreement With Heraeus Medical For Unyvero 28
Curetis Enters Into Distribution Agreement With Advanced Technology For Unyvero Solution 29
Curetis Enters Into Agreement With Sanofi Pasteur For Unyvero Platform 30
Curetis Raises USD44 Million in IPO 31
Curetis NV, Key Competitors 32
Curetis NV, Key Employees 33
Curetis NV, Other Locations 34
Curetis NV, Subsidiaries 34

★海外企業調査レポート[Curetis NV (CURE)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • RPP Infra Projects Ltd (RPPINFRA):企業の財務・戦略的SWOT分析
    RPP Infra Projects Ltd (RPPINFRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Eutelsat Communications S.A. (ETL):企業の財務・戦略的SWOT分析
    Eutelsat Communications S.A. (ETL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • TriGranit Corporation:企業の戦略・SWOT・財務情報
    TriGranit Corporation - Strategy, SWOT and Corporate Finance Report Summary TriGranit Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Unified Grocers, Inc.:戦略・SWOT・企業財務分析
    Unified Grocers, Inc. - Strategy, SWOT and Corporate Finance Report Summary Unified Grocers, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Link Health Group:製薬・医療:M&Aディール及び事業提携情報
    Summary Link Health Group (Link Health) is a pharmaceutical company focused on the discovery and development of novel drug candidates for the treatment of cancer and other diseases. Its pipeline product portfolio includes LH011, an oral small molecule serine protease inhibitor for treating pancreati …
  • Slater and Gordon Limited:企業の戦略・SWOT・財務情報
    Slater and Gordon Limited - Strategy, SWOT and Corporate Finance Report Summary Slater and Gordon Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Baoding Lightway Green Energy Technology Co Ltd:企業の戦略的SWOT分析
    Baoding Lightway Green Energy Technology Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • Exosome Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. Exosome Diagnostics’ services comprise miRNA profiling, mRNA p …
  • German Cancer Research Center-製薬・医療分野:企業M&A・提携分析
    Summary German Cancer Research Center (DKFZ) is a biomedical research institute that develops therapies for the treatment of cancer patients. The institute’s research programs include translational cancer research, cell biology and tumor biology, imaging and radiooncology, cancer risk factors and pr …
  • Superior Industries International, Inc.:企業の戦略・SWOT・財務分析
    Superior Industries International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Superior Industries International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Orbit Garant Drilling Inc.:企業の戦略・SWOT・財務情報
    Orbit Garant Drilling Inc. - Strategy, SWOT and Corporate Finance Report Summary Orbit Garant Drilling Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • H. Lundbeck AS (LUN)-製薬・医療分野:企業M&A・提携分析
    Summary H. Lundbeck A/S (Lundbeck), a subsidiary of The Lundbeck Foundation carries out the research, development, manufacturing and marketing of pharmaceuticals for the treatment of the central nervous system (CNS) related diseases including psychiatric and neurological disorders. Its products are …
  • Genting Plantations Berhad (GENP):企業の財務・戦略的SWOT分析
    Genting Plantations Berhad (GENP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Polaris Industries Inc (PII):企業の財務・戦略的SWOT分析
    Polaris Industries Inc (PII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Genenta Science srl:製薬・医療:M&Aディール及び事業提携情報
    Summary Genenta Science srl (Geneta Science) is a biotechnology company that develops gene therapies based on transcriptional and mirRNA-mediated controls. The company develops gene transfer strategy into autologous hematopoietic stem and progenitor cells in order to target interferon-a expression t …
  • Sykes Enterprises, Incorporated:企業の戦略・SWOT・財務分析
    Sykes Enterprises, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Sykes Enterprises, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • China Pharma Holdings Inc (CPHI):企業の財務・戦略的SWOT分析
    China Pharma Holdings Inc (CPHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Luminex Corp (LMNX):企業の財務・戦略的SWOT分析
    Luminex Corp (LMNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Sequa Corporation:戦略・SWOT・企業財務分析
    Sequa Corporation - Strategy, SWOT and Corporate Finance Report Summary Sequa Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Banco Popular Dominicano S.A.:企業の戦略・SWOT・財務情報
    Banco Popular Dominicano S.A. - Strategy, SWOT and Corporate Finance Report Summary Banco Popular Dominicano S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆